电邮这篇文章 New 1-(2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ols with antituberculosis activity
- 作者: Omel’kov A.V.1, Fedorov V.E.1, Stepanov A.A.1
-
隶属关系:
- Pharm-Sintez
- 期: 卷 68, 编号 10 (2019)
- 页面: 1908-1918
- 栏目: Full Articles
- URL: https://journal-vniispk.ru/1066-5285/article/view/243507
- DOI: https://doi.org/10.1007/s11172-019-2646-5
- ID: 243507
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
New 4-dimethylamino-2-(naphthalen-1-yl)-1-phenyl-1-(quinolin-3-yl)butan-2-ols with antituberculosis activity were synthesized. (1R*,2S*)-1-(6-Bromo-2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ol hydrocitrate exhibiting high antituberculosis activity is in the final stage of clinical trials and is prepared for use in clinical practice.
作者简介
A. Omel’kov
Pharm-Sintez
编辑信件的主要联系方式.
Email: omelkov@mail.ru
俄罗斯联邦, Build. 134, 29 ul. Vereyskaya, Moscow, 121357
V. Fedorov
Pharm-Sintez
Email: omelkov@mail.ru
俄罗斯联邦, Build. 134, 29 ul. Vereyskaya, Moscow, 121357
A. Stepanov
Pharm-Sintez
Email: omelkov@mail.ru
俄罗斯联邦, Build. 134, 29 ul. Vereyskaya, Moscow, 121357
补充文件
